1. Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent results in Cancer Research : Esophageal carcinoma. State of the art. LANGE J & SIEWERT JR. Eds, Springer-Verlag, Berlin 2000;155:1-14. 2. Faivre J, Forman D, Esteve J , Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. Eur. J. Cancer 1998 ; 34 : 2167-2175. 3. FFCD. Que faire devant un cancer digestif en 2003 ? Recommandations de la Fédération Francophone de Cancérologie Digestive (FFCD) – 1ère partie. Gastroenterol Clin Biol 2002;26:1140-64. [on line]. 2005. Available: 4. GERCOR. Les recommandations thérapeutiques (œsophage) [on line]. 2005. 5. Seitz JF, Sarradet A, Francois E, Jacob JH, Ollivier JM, Rougier P, Roussel A. Standards, Options, Recommandations pour la prise en charge des patients atteints de cancer de l’œsophage. In Fédération Nationale des Centres de Lutte Contre le Cancer, ed. Recommandations pour la Pratique Clinique en Cancérologie, Paris 1995, (mise à jour 1997) 6. Seitz JF, Sarradet A, Francois E, Jacob JH, Ollivier JM, Rougier P, et al. Carcinoma of the oesophagus. Br J Cancer 2001;84 Suppl 2:61-4. 7. Giovannini M, Monges G, Seitz JF, Moutardier V, Bernardini D, Thomas P et al. Distant lymph node metastasis in esophageal cancer : impact of endoscopic ultrasound-guided biopsy. Endoscopy 1999;31: 536-40. 8. Van Westreenen HL, Westerterp M, Bossuyt PMM, Pruim J, Sloof GW, Van Landschot JJB, Groen H et al. Systematic review of the staging performance of 18F-Fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004;22:3805-12. 9. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-7. 10. Tio TL, Coene PP, Den Hartog Jager FCA, Tytgat GNJ. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepato-gastroenterol 1990;37:376-81. 11. Siewert JR, Stein HJ. Carcinoma of the cardia : carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esophagus 1996;9:173-82. 12. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9. 13. Mariette C, Piessen G, Balon JM, Van Seuningen I, Triboulet JP. Surgery alone in the curative treatment of localised oesophageal carcinoma. Eur J Surg Oncol 2004;30:869-76. 14. Branagan G, Davies N. Early impact of centralization of esophageal cancer surgery services. Br J Surg 2004;91:1630-2. 15. Birkmeyer JD, Stukel JA, Siewers AE, Goodney PP, Wenneberg DE, Lucas FL. Surgeon volume and operative mortality in the US. N Engl J Med 2003;349:2117-27. 16. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8. 17. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius V, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer : an intergroup study. J Clin Oncol 1997;15:277-84. 18. Jacob JH, Seitz JF, Langlois C, Raoul JL, Bardet E, Bouché O, et al. Definitive concurrent chemoradiation therapy in squamous cell oesophageal cancer. Results of a french randomized trial comparing standard versus split-course irradiation (FNCLCC - FFCD 9305). Proc Am Soc Clin Oncol 1999;18:270a. 19. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74. 20. Bedenne L, Michel P, Bouche O, Triboulet JP, Conroy T, Pezet D, et al. Randomized phase III trial in locally advanced esophageal cancer : radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). J Clin Oncol 2007;25:1160-8 21. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus. J Clin Oncol 2005; 23: 2310-7. 22. Seitz JF, Milan C, Giovannini M, Dumas F, Cauvin JM, Conroy T, et al. Radio-chimiothérapie concomitante concentrée dans les cancers épidermoides de l’oesophage. Résultats à long terme d’un essai national multicentrique de phase II chez 122 patients non opérables. Gastroenterol Clin Biol 2000; 24:201-210. 23. Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004;364:1497-1504. 24. Walsh TN, Noonan N, Holywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7. 25. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastière A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:283-5. 26. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D et al. A randomised study of chemotherapy, radiation therapy, and surgery versus surgery for localised squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84. 27. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterol 1994;41:391-3. 28. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-43. 29. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754-761. 30. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the esophagus: a randomised controlled phase III trial. Lancet Oncol 2005;6:659-68. 31. Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for respectable esophageal squamous cell carcinoma. Ann Oncol 2004;15:947-54. 32. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 1997;33:1216-20. 33. Taieb J, Mitry E, Boige V, Artru P, Ezenfis J, Lecomte T, et al. Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol 2002;13:1192-6. 34. Mitry E, Taieb J, Artru P, Boige V, Vaillant JN, Clavero-Fabri MC, et al. Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma. Ann Oncol 2004;15:765-9. 35. Conroy T, Etienne PL, Adenis A, Ducreux M, Paillot B, Oliveira J, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 2002;13:721-9. 36. Kroep JR, Pinedo HM, Giaccone G, Van Bochove A, Peters GJ, Van Groeningen CJ. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Ann Oncol 2004;15:230-5. 37. Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, et al. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 1999;17:3270-5. 38. Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, et al. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer 2002;94:641-6. 39. Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 2000;6:316-23. 40. Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998;16:1826-34. 41. Lokich JJ, Sonneborn H, Anderson NR, Bern MM, Coco FV, Dow E, et al. Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas. Cancer 1999;85:2347-51. 42. Assersohn L, Brown G, Cunningham D, Ward C, Oates J, Waters JS, et al. Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol 2004;15:64-9. 43. Medical Research Council Oesophageal Cancer Working party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer : a randomised controlled trial. Lancet 2002;359:1727-33. 44. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-43. 45. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol 2003;21:4592-6. 46. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-7. 47. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995;108:337-44. 48. Maingon P, d'Hombres A, Truc G, Barillot I, Michiels C, Bedenne L, et al. High dose rate brachytherapy for superficial cancer of the esophagus. Int J Radiat Oncol Biol Phys 2000;46:71-6. 49. Dahan L, Ries P, Laugier R, Seitz JF. Traitement endoscopique palliatif du cancer de l'oesophage. Gastroenterol Clin Biol 2006;30:253-61. 50. Wenger U, Luo J, Lundell L, Lagergren J. A nationwide study of the use of self-expanding stents in patients with esophageal cancer in sweden. Endoscopy 2005;37:329-34. 51. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A Controlled trial of expansible metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329:1302-7. 52. Siersema PD, Hop WC, Dees J, Tilaners HW, Van Blankenstein M. Coated self expanding metal stent versus latex prosthesis for esophagogastric cancer with special reference to prior radiation and chemotherapy : a controlled, prospective study. Gastrointest Endosc 1998;47:113-20. 53. De Palma GD, Di Matteo E, Romano G, Fimmano A, Mondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma : a controlled prospective study. Gastrointest Endosc 1996;43:478-82. 54. Roseveare CD, Patel P, Simmonds N, Goggin PM, Kimble J, Shepherd HA. Metal stents improve dysphagia, nutrition and survival in malignant esophageal stenosis : a randomized controlled trial comparing modified Gianturco Z stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol 1998;10:653-7. 55. Christie NA, Buenaventura PO, Fernando HC, Nguyen NT, Weigel TL, Ferson PF, et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients : short term and long term follow up. Ann Throc Surg 2001;71:1797-802. 56. Lecleire S, Di Fiore F, Antonietti M, Ducrotté P, Paillot B, Michel P, et al. Les prothèses oesophagiennes métalliques expansives dans le traitement palliatif du cancer de l’œsophage : comparaison des résultats et des complicatins chez 56 malades ayant reçu une radiochimiothérapie versus 60 malades non traités antérieurement. Gastroenterol Clin Biol 2005;29:A2. (abstract) 57. Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:4336-41. 58. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52. 59. Seitz JF. Cancer de l’oesophage: place de la chimiothérapie et de la radiochimiothérapie. In « Place de la chimiothérapie dans la stratégie thérapeutique des cancers digestifs », Rougier P, Ducreux M, Seitz JF eds, John Libbey Eurotext, Paris 2001;12-43. 60. Siewert JR, Stein HJ, Feith M, Bruecher BLDM, Bartels H, Fink U. Histologic tumor type is an independant prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the western world. Ann Surg 2001; 234: 360-9. 61. Roussel A, Chèze S, Jacob JH, Ollivier JM, Macé-Lesech J, Henry-Amar M. Radiation therapy in esophageal carcinoma with broncho-tracheal involvement. Proc Am Soc Clin Oncol 1995; 14: 438a. 62. Bossard N, Bouvier AM , Binquet C, Gagnaire A, Jouve JL, Faivre J, Bedenne L. Management and prognosis of esophageal cancer : has progress been made ? Eur J Cancer 2006 ;42 :228-33. 63. Mariette C, Fabre S, Balon JM, Finzi L,Triboulet JP. Facteurs prédictifs de résection des cancers de l’œsophage opérables. A propos de 740 cas. Gastroenterol Clin Biol 2002 ;26 :454-62 64. Krasna MJ, Reed CE, Nedzwiecki D, Hollis DR, Luketich JD, De Camp MM et al. CALGB 9380 : a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging oesophageal cancer. Ann Thorac Surg 2001;71:1073-9 65. Wurtz A, Chastenet P. Carcinome épidermoïde de l’œsophage thoracique : quelle classification tomodensitométrique ? Gastroenterol Clin Biol 1988;12:921-5 66. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2003, 58, N° 6 (Suppl) 67. Fumagalli U and Panel of experts. Resective surgery for cancer of the thoracic esophagus. Results of a Consensus Conference at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esoph 1996;9 Suppl.1, 30-38 68. Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (oesophageal cancer collaborative group) Int J Radiation Oncology Biol Phys 1998; 41:579-83 69. Fiorica F, Di Bona D, Schepis F, Licata A, Shahie DL, Venturi A et al. Preoperative radiochemotherapy for oesophageal cancer : a systematic review and meta-analysis. Gut 2004;53:925-30 70. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefit from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226-34 71. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996;14:156-163 72. Piessen G, Briez N, Triboulet JP, Mariette C. Patients with locally advanced oesophageal carcinoma non responder to radiochemotherapy : who will benefit from surgery ? Ann Surg Oncol 2007 sous presse 73. Dresner SM, Griffin SM. Pattern of recurrence following radical esophagectomy with two-field lymphadenectomy. Br J Surg 2000; 87: 1426-33 74. Mariette C, Balon JM, Piessen G, Fabre S, van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616-23 75. Malthaner RA, Collin S, Fenlon D.Preoperative chemotherapy for resectable thoracic esophageal cancer (review). The Cochrane Library 2006, issue 4 76. Profili S, Meloni GB, Feo CF, Pischedda A, Bozzo C, Ginesu GC, Canalis GC. Self-expandable metal stents in the management of cervical esophagus and/or hypopharyngeal strictures. Clin Radiol 2002;57:1028-33 77. Rice TW, Mason DP, Murthy SC, Zuccaro G, Adelstein DJ, Rybicki LA, Blackstone EA. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 2007 ;133 :317-24